Ramucirumab

From WikiMD.org
Jump to navigation Jump to search
Ramucirumab
TermRamucirumab
Short definitionramucirumab - (pronounced) (RA-myoo-SIR-yoo-mab) A drug that binds to the protein vascular endothelial growth factor (VEGF) to prevent new blood vessels from forming and is used to treat various types of cancer. It is used alone or with other medicines to treat certain types of non-small cell lung cancer, hepatocellular carcinoma (a type of liver cancer), colon cancer, stomach cancer and cancer of the gastro-oesophageal junction. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


ramucirumab - (pronounced) (RA-myoo-SIR-yoo-mab) A drug that binds to the protein vascular endothelial growth factor (VEGF) to prevent new blood vessels from forming and is used to treat various types of cancer. It is used alone or with other medicines to treat certain types of non-small cell lung cancer, hepatocellular carcinoma (a type of liver cancer), colon cancer, stomach cancer and cancer of the gastro-oesophageal junction. It is also being studied in the treatment of other types of cancer. Ramucirumab can prevent the growth of new blood vessels that tumors need to grow. It's a type of anti-angiogenesis drug and a type of monoclonal antibody. Also referred to as fully human anti-VEGFR-2 monoclonal antibody IMC-1121B, Cyramza and IMC-1121B

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski